Soliton Announces Oral Presentation at American Society for Laser Medicine and Surgery Virtual Annual Conference
HOUSTON, April 27, 2021 /PRNewswire/ — Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology, today announced that the 52-week results from its pivotal cellulite trial have been accepted for an oral…
Comments Off on Soliton Announces Oral Presentation at American Society for Laser Medicine and Surgery Virtual Annual Conference